샘플 요청 목록

 카트 문의
시장보고서
상품코드
2034220

타박상 치료 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)

Bruise Treatment Market Insights, Competitive Landscape, and Market Forecast - 2033
발행일: | 리서치사: 구분자 Fairfield Market Research | 페이지 정보: 영문 189 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



가격
Unprintable PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,995 금액 안내 화살표 ￦ 7,690,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.
US $ 8,495 금액 안내 화살표 ￦ 13,079,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,600 금액 안내 화살표 ￦ 16,320,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

피부 손상과 효과적인 치료법에 대한 인식이 높아지면서 세계 타박상 치료 시장은 꾸준히 성장하고 있습니다. 타박상은 주로 피하 혈관의 외상에 의해 발생하며, 모든 연령대에서 가장 흔하게 나타나는 경미한 부상 중 하나입니다. 빠른 치유, 피부 개선, 그리고 쉽게 구할 수 있는 셀프 케어 제품에 대한 소비자의 관심이 높아지면서 타박상 치료 솔루션에 대한 수요가 증가하고 있습니다. 시장은 첨단 의약품 제제, 외용제, 허브 기반 치료제의 도입으로 진화하고 있으며, 다양한 소비자의 취향을 충족시키고 있습니다.

시장 인사이트

타박상 치료 시장 규모는 2026년에 3억 4,330만 달러에 달했으며, 2033년까지 4억 5,540만 달러로 성장할 것으로 예상되며, 예측 기간 동안 4.10%의 CAGR로 확대될 것으로 예상됩니다. 이러한 꾸준한 성장은 경미한 부상의 증가, 신체 활동 참여의 증가, 시판되는 건강 관리 제품에 대한 소비자의 관심 증가를 반영합니다. 크림, 젤, 스프레이, 경구용 약품 등 다양한 치료 형태가 가능한 것이 전 세계 시장 침투를 촉진하고 있습니다.

시장 촉진요인

타박상 치료 시장을 이끄는 주요 요인은 스포츠, 사고, 일상 활동으로 인한 부상 발생률의 증가입니다. 피트니스와 아웃도어 스포츠를 즐기는 사람들이 늘어남에 따라 타박상을 입을 가능성이 높아지면서 효과적이고 즉각적인 치료 제품에 대한 수요가 증가하고 있습니다. 또한, 고령화가 진행되면서 피부 탄력 저하와 모세혈관 약화로 인해 타박상을 입기 쉬워지고 있는 것도 시장 확대에 기여하고 있습니다.

셀프 메디케이션의 증가 추세와 일반의약품에 대한 쉬운 접근성 또한 중요한 역할을 하고 있습니다. 소비자들은 경미한 부상에 대해 의사의 진찰을 필요로 하지 않는 편리하고 빠른 해결책을 선호합니다. 소매 약국 및 EC 플랫폼의 확대로 제품의 가용성이 크게 향상되어 소비자는 정보에 입각한 구매 결정을 내릴 수 있게 되었습니다.

또한, 제형 기술의 지속적인 발전과 천연 성분의 배합이 시장 성장을 촉진하고 있습니다. 각 제조사들은 회복 촉진, 염증 완화, 부작용을 최소화하는 제품 개발에 주력하고 있으며, 이를 통해 소비자의 신뢰와 제품 선호도를 높이고 있습니다.

비즈니스 기회

이 시장에는 특히 허브 및 유기농 타박상 치료 제품 개발에서 큰 성장 기회가 존재합니다. 자연요법에 대한 소비자 선호도가 높아지면서 아르니카, 비타민K, 식물 유래 추출물 등의 성분을 함유한 제제에 대한 수요가 증가하고 있습니다. 이러한 제품 혁신에 투자하는 기업은 경쟁 우위를 확보할 가능성이 높습니다.

신흥국 시장에서는 의료 인프라 개선, 가처분 소득 증가, 퍼스널케어에 대한 인식이 높아지면서 유망한 성장 기회가 창출되고 있습니다. 기업은 가성비 좋은 제품을 도입하고, 미개척 시장에서의 유통망을 강화함으로써 이러한 기회를 활용할 수 있습니다.

약물전달 시스템의 기술 혁신도 새로운 성장의 길을 열어가고 있습니다. 흡수가 빠른 외용제나 병용요법의 개발은 치료 결과를 크게 개선할 수 있습니다. 전략적 제휴, 인수, 신제품 출시로 시장 경쟁이 더욱 치열해질 것으로 예상됩니다.

지역별 분석

북미는 선진화된 의료 인프라, 높은 소비자 의식, 그리고 주요 기업의 강력한 입지를 바탕으로 타박상 치료 시장을 독점하고 있습니다. 이 지역은 또한 잘 발달된 일반의약품 시장과 높은 스포츠 관련 부상 발생률의 혜택을 누리고 있습니다.

유럽은 자연요법과 동종요법에 대한 선호도가 높아지면서 큰 비중을 차지하고 있습니다. 허브 제품에 대한 수요 증가와 우호적인 규제 환경이 이 지역의 시장 성장을 뒷받침하고 있습니다.

아시아태평양은 예측 기간 동안 가장 빠른 성장을 보일 것으로 예상됩니다. 방대한 인구 기반, 의료에 대한 인식 증가, 스킨케어 제품 보급 확대 등의 요인이 이 지역의 수요를 견인하고 있습니다. 또한, E-Commerce 플랫폼과 전통 의학의 영향력 확대도 시장 확대를 더욱 촉진하고 있습니다.

라틴아메리카와 중동 및 아프리카는 의료 접근성 향상과 소비자 인식 개선에 힘입어 점차 잠재적인 시장으로 부상하고 있습니다.

주요 기업

이 시장은 제품 혁신과 전략적 확장을 통해 경쟁을 펼치는 수많은 세계 및 지역 기업들이 진출해 있는 것이 특징입니다. 주요 기업은 다음과 같습니다:

  • Boiron Group
  • STADA Arzneimittel AG
  • Bioderma
  • Zealous Health Private Limited
  • Pharmavite LLC
  • Topix Pharmaceuticals, Inc.
  • TriDerma
  • Zax Healthcare
  • Reckitt Benckiser Group plc
  • Sanofi
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Himalaya Wellness Company

이들 기업은 시장에서의 입지를 유지하기 위해 제품 라인업 확대, 세계 진출 강화, 연구개발 투자에 적극 나서고 있습니다.

세분화

치료법별

  • 항염증제(NSAIDs, 스테로이드)
  • 항응고제
  • 기타

질환별

  • 혈종
  • 자반
  • 점상 출혈
  • 기타

적응증별

  • 출혈성 질환
  • 비타민 결핍증
  • 피부 손상
  • 기타

최종사용자별

  • 병원
  • 진료소
  • 기타

유통 채널별

  • 병원 내 약국
  • 소매 약국
  • 온라인/E-Commerce

지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

제3장 세계의 타박상 치료 시장 전망, 2020-2033년

제4장 북미의 타박상 치료 시장 전망, 2020-2033년

제5장 유럽의 타박상 치료 시장 전망, 2020-2033년

제6장 아시아태평양의 타박상 치료 시장 전망, 2020-2033년

제7장 라틴아메리카의 타박상 치료 시장 전망, 2020-2033년

제8장 중동 및 아프리카의 타박상 치료 시장 전망, 2020-2033년

제9장 경쟁 구도

제10장 부록

KSM 26.05.27

The global Bruise Treatment Market is experiencing consistent growth as awareness regarding skin injuries and effective treatment solutions continues to rise. Bruises, commonly caused by trauma to underlying blood vessels, are among the most frequent minor injuries across all age groups. Increasing consumer focus on faster healing, improved skin appearance, and accessible self-care products is driving demand for bruise treatment solutions. The market is evolving with the introduction of advanced pharmaceutical formulations, topical applications, and herbal-based remedies, catering to a wide range of consumer preferences.

Market Insights

The Bruise Treatment Market is projected to reach USD 343.3 million in 2026 and is anticipated to grow to USD 455.4 million by 2033, expanding at a CAGR of 4.10% during the forecast period. This steady growth reflects the rising prevalence of minor injuries, increasing participation in physical activities, and growing consumer inclination toward over-the-counter healthcare products. The availability of multiple treatment formats, such as creams, gels, sprays, and oral medications, continues to support market penetration globally.

Market Drivers

A primary factor driving the bruise treatment market is the increasing incidence of injuries associated with sports, accidents, and daily activities. As more individuals engage in fitness routines and outdoor sports, the likelihood of bruising has increased, boosting demand for effective and fast-acting treatment products. Additionally, the growing elderly population is more susceptible to bruising due to reduced skin elasticity and fragile capillaries, further contributing to market expansion.

The rising trend of self-medication and easy accessibility of over-the-counter products is also playing a crucial role. Consumers prefer convenient and quick solutions that do not require medical consultation for minor injuries. The expansion of retail pharmacies and e-commerce platforms has significantly improved product availability, allowing consumers to make informed purchasing decisions.

Moreover, continuous advancements in drug formulations and the incorporation of natural ingredients are strengthening market growth. Manufacturers are focusing on developing products that offer quicker recovery, reduced inflammation, and minimal side effects, thereby enhancing consumer trust and adoption.

Business Opportunity

The market presents substantial growth opportunities, particularly in the development of herbal and organic bruise treatment products. Increasing consumer preference for natural remedies has led to rising demand for formulations containing ingredients such as arnica, vitamin K, and plant-based extracts. Companies investing in such product innovations are likely to gain a competitive advantage.

Emerging economies offer promising expansion opportunities due to improving healthcare infrastructure, rising disposable incomes, and growing awareness about personal care. Companies can leverage these opportunities by introducing cost-effective products and strengthening their distribution networks in untapped markets.

Technological innovation in drug delivery systems also presents new avenues for growth. The development of fast-absorbing topical solutions and combination therapies can significantly improve treatment outcomes. Strategic partnerships, acquisitions, and product launches are expected to further drive market competitiveness.

Region Analysis

North America dominates the Bruise Treatment Market, supported by advanced healthcare infrastructure, high consumer awareness, and strong presence of leading pharmaceutical companies. The region also benefits from a well-established over-the-counter drug market and high incidence of sports-related injuries.

Europe holds a significant share, driven by growing preference for natural and homeopathic treatments. Increasing demand for herbal-based products and favorable regulatory frameworks are supporting market growth in the region.

Asia Pacific is expected to witness the fastest growth during the forecast period. Factors such as a large population base, rising healthcare awareness, and increasing adoption of skincare products are driving regional demand. The growing influence of e-commerce platforms and traditional medicine practices further supports market expansion.

Latin America and the Middle East & Africa are gradually emerging as potential markets, supported by improving healthcare access and increasing consumer awareness.

Key Players

The market is characterized by the presence of several global and regional players competing through product innovation and strategic expansion. Key companies include:

  • Boiron Group
  • STADA Arzneimittel AG
  • Bioderma
  • Zealous Health Private Limited
  • Pharmavite LLC
  • Topix Pharmaceuticals, Inc.
  • TriDerma
  • Zax Healthcare
  • Reckitt Benckiser Group plc
  • Sanofi
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Himalaya Wellness Company

These companies are actively focusing on expanding their product offerings, enhancing global reach, and investing in research and development to maintain market position.

Segmentation

By Treatment Type

  • Anti-inflammatory Drugs (NSAIDs, steroids)
  • Anti-coagulant Drugs
  • Others

By Disease Type

  • Hematoma
  • Purpura
  • Petechiae
  • Others

By Indication

  • Bleeding Disorders
  • Vitamin Deficiencies
  • Skin Injury
  • Others

By End User

  • Hospitals
  • Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online / E-commerce

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bruise Treatment Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Bruise Treatment Market Outlook, 2020 - 2033

  • 3.1. Global Bruise Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2020-2033
    • 3.1.1. Anti-inflammatory Drugs (NSAIDs, steroids)
    • 3.1.2. Anti-coagulant Drugs
    • 3.1.3. Others
  • 3.2. Global Bruise Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2020-2033
    • 3.2.1. Hematoma
    • 3.2.2. Purpura
    • 3.2.3. Petechiae
    • 3.2.4. Others
  • 3.3. Global Bruise Treatment Market Outlook, by Indication, Value (US$ Mn), 2020-2033
    • 3.3.1. Bleeding Disorders
    • 3.3.2. Vitamin Deficiencies
    • 3.3.3. Skin Injury
    • 3.3.4. Others
  • 3.4. Global Bruise Treatment Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Clinics
    • 3.4.3. Others
  • 3.5. Global Bruise Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
    • 3.5.1. Hospital Pharmacies
    • 3.5.2. Retail Pharmacies
    • 3.5.3. Online / E-commerce
  • 3.6. Global Bruise Treatment Market Outlook, by Region, Value (US$ Mn), 2020-2033
    • 3.6.1. North America
    • 3.6.2. Europe
    • 3.6.3. Asia Pacific
    • 3.6.4. Latin America
    • 3.6.5. Middle East & Africa

4. North America Bruise Treatment Market Outlook, 2020 - 2033

  • 4.1. North America Bruise Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2020-2033
    • 4.1.1. Anti-inflammatory Drugs (NSAIDs, steroids)
    • 4.1.2. Anti-coagulant Drugs
    • 4.1.3. Others
  • 4.2. North America Bruise Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2020-2033
    • 4.2.1. Hematoma
    • 4.2.2. Purpura
    • 4.2.3. Petechiae
    • 4.2.4. Others
  • 4.3. North America Bruise Treatment Market Outlook, by Indication, Value (US$ Mn), 2020-2033
    • 4.3.1. Bleeding Disorders
    • 4.3.2. Vitamin Deficiencies
    • 4.3.3. Skin Injury
    • 4.3.4. Others
  • 4.4. North America Bruise Treatment Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Clinics
    • 4.4.3. Others
  • 4.5. North America Bruise Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
    • 4.5.1. Hospital Pharmacies
    • 4.5.2. Retail Pharmacies
    • 4.5.3. Online / E-commerce
  • 4.6. North America Bruise Treatment Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 4.6.1. U.S. Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 4.6.2. U.S. Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 4.6.3. U.S. Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 4.6.4. U.S. Bruise Treatment Market Outlook, by End User, 2020-2033
    • 4.6.5. U.S. Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 4.6.6. Canada Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 4.6.7. Canada Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 4.6.8. Canada Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 4.6.9. Canada Bruise Treatment Market Outlook, by End User, 2020-2033
    • 4.6.10. Canada Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
  • 4.7. BPS Analysis/Market Attractiveness Analysis

5. Europe Bruise Treatment Market Outlook, 2020 - 2033

  • 5.1. Europe Bruise Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2020-2033
    • 5.1.1. Anti-inflammatory Drugs (NSAIDs, steroids)
    • 5.1.2. Anti-coagulant Drugs
    • 5.1.3. Others
  • 5.2. Europe Bruise Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2020-2033
    • 5.2.1. Hematoma
    • 5.2.2. Purpura
    • 5.2.3. Petechiae
    • 5.2.4. Others
  • 5.3. Europe Bruise Treatment Market Outlook, by Indication, Value (US$ Mn), 2020-2033
    • 5.3.1. Bleeding Disorders
    • 5.3.2. Vitamin Deficiencies
    • 5.3.3. Skin Injury
    • 5.3.4. Others
  • 5.4. Europe Bruise Treatment Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Clinics
    • 5.4.3. Others
  • 5.5. Europe Bruise Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
    • 5.5.1. Hospital Pharmacies
    • 5.5.2. Retail Pharmacies
    • 5.5.3. Online / E-commerce
  • 5.6. Europe Bruise Treatment Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 5.6.1. Germany Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.2. Germany Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.3. Germany Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.4. Germany Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.5. Germany Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.6. Italy Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.7. Italy Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.8. Italy Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.9. Italy Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.10. Italy Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.11. France Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.12. France Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.13. France Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.14. France Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.15. France Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.16. U.K. Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.17. U.K. Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.18. U.K. Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.19. U.K. Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.20. U.K. Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.21. Spain Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.22. Spain Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.23. Spain Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.24. Spain Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.25. Spain Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.26. Russia Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.27. Russia Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.28. Russia Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.29. Russia Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.30. Russia Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 5.6.31. Rest of Europe Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 5.6.32. Rest of Europe Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 5.6.33. Rest of Europe Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 5.6.34. Rest of Europe Bruise Treatment Market Outlook, by End User, 2020-2033
    • 5.6.35. Rest of Europe Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
  • 5.7. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Bruise Treatment Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Bruise Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2020-2033
    • 6.1.1. Anti-inflammatory Drugs (NSAIDs, steroids)
    • 6.1.2. Anti-coagulant Drugs
    • 6.1.3. Others
  • 6.2. Asia Pacific Bruise Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2020-2033
    • 6.2.1. Hematoma
    • 6.2.2. Purpura
    • 6.2.3. Petechiae
    • 6.2.4. Others
  • 6.3. Asia Pacific Bruise Treatment Market Outlook, by Indication, Value (US$ Mn), 2020-2033
    • 6.3.1. Bleeding Disorders
    • 6.3.2. Vitamin Deficiencies
    • 6.3.3. Skin Injury
    • 6.3.4. Others
  • 6.4. Asia Pacific Bruise Treatment Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Others
  • 6.5. Asia Pacific Bruise Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
    • 6.5.1. Hospital Pharmacies
    • 6.5.2. Retail Pharmacies
    • 6.5.3. Online / E-commerce
  • 6.6. Asia Pacific Bruise Treatment Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 6.6.1. China Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 6.6.2. China Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 6.6.3. China Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 6.6.4. China Bruise Treatment Market Outlook, by End User, 2020-2033
    • 6.6.5. China Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.6. Japan Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 6.6.7. Japan Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 6.6.8. Japan Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 6.6.9. Japan Bruise Treatment Market Outlook, by End User, 2020-2033
    • 6.6.10. Japan Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.11. South Korea Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 6.6.12. South Korea Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 6.6.13. South Korea Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 6.6.14. South Korea Bruise Treatment Market Outlook, by End User, 2020-2033
    • 6.6.15. South Korea Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.16. India Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 6.6.17. India Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 6.6.18. India Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 6.6.19. India Bruise Treatment Market Outlook, by End User, 2020-2033
    • 6.6.20. India Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.21. Southeast Asia Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 6.6.22. Southeast Asia Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 6.6.23. Southeast Asia Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 6.6.24. Southeast Asia Bruise Treatment Market Outlook, by End User, 2020-2033
    • 6.6.25. Southeast Asia Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 6.6.26. Rest of SAO Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 6.6.27. Rest of SAO Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 6.6.28. Rest of SAO Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 6.6.29. Rest of SAO Bruise Treatment Market Outlook, by End User, 2020-2033
    • 6.6.30. Rest of SAO Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
  • 6.7. BPS Analysis/Market Attractiveness Analysis

7. Latin America Bruise Treatment Market Outlook, 2020 - 2033

  • 7.1. Latin America Bruise Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2020-2033
    • 7.1.1. Anti-inflammatory Drugs (NSAIDs, steroids)
    • 7.1.2. Anti-coagulant Drugs
    • 7.1.3. Others
  • 7.2. Latin America Bruise Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2020-2033
    • 7.2.1. Hematoma
    • 7.2.2. Purpura
    • 7.2.3. Petechiae
    • 7.2.4. Others
  • 7.3. Latin America Bruise Treatment Market Outlook, by Indication, Value (US$ Mn), 2020-2033
    • 7.3.1. Bleeding Disorders
    • 7.3.2. Vitamin Deficiencies
    • 7.3.3. Skin Injury
    • 7.3.4. Others
  • 7.4. Latin America Bruise Treatment Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Others
  • 7.5. Latin America Bruise Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
    • 7.5.1. Hospital Pharmacies
    • 7.5.2. Retail Pharmacies
    • 7.5.3. Online / E-commerce
  • 7.6. Latin America Bruise Treatment Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 7.6.1. Brazil Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 7.6.2. Brazil Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 7.6.3. Brazil Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 7.6.4. Brazil Bruise Treatment Market Outlook, by End User, 2020-2033
    • 7.6.5. Brazil Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 7.6.6. Mexico Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 7.6.7. Mexico Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 7.6.8. Mexico Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 7.6.9. Mexico Bruise Treatment Market Outlook, by End User, 2020-2033
    • 7.6.10. Mexico Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 7.6.11. Argentina Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 7.6.12. Argentina Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 7.6.13. Argentina Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 7.6.14. Argentina Bruise Treatment Market Outlook, by End User, 2020-2033
    • 7.6.15. Argentina Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 7.6.16. Rest of LATAM Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 7.6.17. Rest of LATAM Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 7.6.18. Rest of LATAM Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 7.6.19. Rest of LATAM Bruise Treatment Market Outlook, by End User, 2020-2033
    • 7.6.20. Rest of LATAM Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
  • 7.7. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Bruise Treatment Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Bruise Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2020-2033
    • 8.1.1. Anti-inflammatory Drugs (NSAIDs, steroids)
    • 8.1.2. Anti-coagulant Drugs
    • 8.1.3. Others
  • 8.2. Middle East & Africa Bruise Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2020-2033
    • 8.2.1. Hematoma
    • 8.2.2. Purpura
    • 8.2.3. Petechiae
    • 8.2.4. Others
  • 8.3. Middle East & Africa Bruise Treatment Market Outlook, by Indication, Value (US$ Mn), 2020-2033
    • 8.3.1. Bleeding Disorders
    • 8.3.2. Vitamin Deficiencies
    • 8.3.3. Skin Injury
    • 8.3.4. Others
  • 8.4. Middle East & Africa Bruise Treatment Market Outlook, by End User, Value (US$ Mn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Clinics
    • 8.4.3. Others
  • 8.5. Middle East & Africa Bruise Treatment Market Outlook, by Distribution Channel, Value (US$ Mn), 2020-2033
    • 8.5.1. Hospital Pharmacies
    • 8.5.2. Retail Pharmacies
    • 8.5.3. Online / E-commerce
  • 8.6. Middle East & Africa Bruise Treatment Market Outlook, by Country, Value (US$ Mn), 2020-2033
    • 8.6.1. GCC Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 8.6.2. GCC Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 8.6.3. GCC Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 8.6.4. GCC Bruise Treatment Market Outlook, by End User, 2020-2033
    • 8.6.5. GCC Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.6. South Africa Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 8.6.7. South Africa Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 8.6.8. South Africa Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 8.6.9. South Africa Bruise Treatment Market Outlook, by End User, 2020-2033
    • 8.6.10. South Africa Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.11. Egypt Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 8.6.12. Egypt Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 8.6.13. Egypt Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 8.6.14. Egypt Bruise Treatment Market Outlook, by End User, 2020-2033
    • 8.6.15. Egypt Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.16. Nigeria Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 8.6.17. Nigeria Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 8.6.18. Nigeria Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 8.6.19. Nigeria Bruise Treatment Market Outlook, by End User, 2020-2033
    • 8.6.20. Nigeria Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
    • 8.6.21. Rest of Middle East Bruise Treatment Market Outlook, by Treatment Type, 2020-2033
    • 8.6.22. Rest of Middle East Bruise Treatment Market Outlook, by Disease Type, 2020-2033
    • 8.6.23. Rest of Middle East Bruise Treatment Market Outlook, by Indication, 2020-2033
    • 8.6.24. Rest of Middle East Bruise Treatment Market Outlook, by End User, 2020-2033
    • 8.6.25. Rest of Middle East Bruise Treatment Market Outlook, by Distribution Channel, 2020-2033
  • 8.7. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Boiron Group
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. STADA Arzneimittel AG
    • 9.4.3. Bioderma (NAOS Group)
    • 9.4.4. Zealous Health Private Limited
    • 9.4.5. Pharmavite LLC
    • 9.4.6. Topix Pharmaceuticals, Inc.
    • 9.4.7. TriDerma
    • 9.4.8. Zax Healthcare
    • 9.4.9. Reckitt Benckiser Group plc
    • 9.4.10. Sanofi
    • 9.4.11. GlaxoSmithKline plc
    • 9.4.12. Pfizer Inc.
    • 9.4.13. Johnson & Johnson
    • 9.4.14. Bausch Health Companies Inc.
    • 9.4.15. Himalaya Wellness Company

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기